In classical/Greek-based medical terminology, many singular nouns ending inĀ -omaĀ (e.g.,Ā hematoma, fibroma, carcinoma, sarcoma) can take the pluralĀ -omataĀ (hematomata, fibromata, carcinomata, sarcomata). This is the older, more classical plural; in modern clinical English, you will also see and chartĀ -omasĀ as an acceptable plural (e.g., āmultiple fibromasā), butĀ -omataĀ is still correct and shows up in pathology texts and some formal writing.
-omaĀ comes from GreekĀ -ÅmaĀ āĻμαāĻμα, a noun-forming suffix meaning āresult,ā āproduct,ā or āswelling/tumor,ā especially in a pathological sense.
TheĀ plural in GreekĀ isĀ -ÅmataĀ āĻĖμαĻαāĻĖμαĻα, which is anglicized asĀ -omataĀ in medical terms.
English later also created the simpler regular pluralĀ -omas, so you now haveĀ two plurals in use:Ā sarcomasĀ andĀ sarcomataĀ are both correct.
-itisĀ (inflammation) andĀ -omaĀ can intersect in cancer terms historically (e.g.,Ā lymphomaĀ vsĀ lymphadenitis).
Coding angle (ICD-10-CM/CPT)
Coding systems donāt distinguish betweenĀ -omaĀ andĀ -omata / -omas; they just care about:
TheĀ typeĀ of tumor (benign vs malignant, site, histology).
TheĀ numberĀ andĀ locationĀ when that impacts code choice or modifiers.
Examples youāll see conceptually (no single code for ā-omataā):
Malignant neoplasms (e.g., various C codes in ICD-10-CM for carcinomas, sarcomas).
Benign neoplasms (D codes) or neoplasms of uncertain behavior, all built on -oma roots in the diagnostic term.
For your Obsidian setup, Iād giveĀ -omaĀ its main entry and noteĀ -omataĀ under it as āclassical plural of -oma = multiple tumors/masses,ā with a quick reminder that modern charts often useĀ -omasĀ instead.